Health Insurers Outline Medicare Expansion Plans
In March, Aetna realigned its Medicare, Medicaid, public and labor, and federal benefit planned businesses into a single operating unit, Government Services. Aetna officials say the change will help the insurer better serve its government customers, advance its retiree solutions and position it for the dual-eligible market.
Although Aetna continues to look at acquisition targets, officials say they haven't seen anything in a price point that makes sense for Aetna.
CIGNA now provides real-time pricing for more than 200 common medical procedures, which represent 80% of its medical claims.
Its collaborative accountable care program (CAC) is a physician engagement program that provides physicians with actionable patient information to close gaps in care, financial incentives, and assistance from care coordinators to help patients follow prescribed treatments and improve their overall health by participating in coaching and lifestyle programs. Humana has 22 of these initiatives in place in 13 states. It plans to have 100 in place by 2014.
CIGNA acquired HealthSpring, a Medicare plan, in 2011 and is leveraging its larger business footprint to expand HealthSpring's senior offerings into new markets.
CIGNA is also preparing for an increase in utilization in 2012, although the first quarter increase was "muted" according to company officials. The insurer continues to see targeted increases in what it calls "good utilization," including some prevention, wellness, and diagnostic procedures as well as higher medication compliance around evidenced-based care for members in chronic programs.
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening